>>This phrase is industry standard; it means that, if a company who is not a party to the settlement launches its own generic drug before the agreed upon launch date in the settlement, the generic-drug company that is a party to the settlement can launch its generic at the same time.
Yes, that's the standard anti-competitive trick that prevents any other generic companies from wasting their time challenging the patent. I think Niaspan (then Kos Pharma) was the first time I saw this idea used.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.